News

news
Daratumumab (DARZALEX) approved in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma.

By IBR Solutions | 23rd November, 2016

Daratumumab (DARZALEX) approved in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma. Read more

USFDA approves Essure labeling with important safety information for patients and physicians.

By IBR Solutions | 17th November, 2016

USFDA approves Essure labeling with important safety information for patients and physicians. Read more

Selzentry approved for pediatric use

By IBR Solutions | 21st November, 2016

Selzentry approved for pediatric use Read more

Sunscreen Guidance outlines safety and effectiveness data recommended for additional active ingredients

By IBR Solutions | 23rd November, 2016

Sunscreen Guidance outlines safety and effectiveness data recommended for additional active ingredients Read more

FDA approves LARTRUVO (olaratumab), in combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma

By IBR Solutions | 5th November, 2016

FDA approves LARTRUVO (olaratumab), in combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma Read more

Warning Letter: Beijing Taiyang Pharmaceutical Industry Co Ltd

By IBR Solutions | 5th November, 2016

Warning Letter: Beijing Taiyang Pharmaceutical Industry Co Ltd Read more

Two Genetic Markers that Predict Malaria Treatment Failure Found

By IBR Solutions | 5th November, 2016

Two Genetic Markers that Predict Malaria Treatment Failure Found Read more

FDA approves new device for prevention of recurrent strokes in certain patients

By IBR Solutions | 5th November, 2016

FDA approves new device for prevention of recurrent strokes in certain patients Read more

Warning Letter: CP Pharmaceuticals (Wockhardt Limited)

By IBR Solutions | 24th November, 2016

Warning Letter: CP Pharmaceuticals (Wockhardt Limited) Read more

Copyright © 2018 IBRSoluTions. All rights reserved Hand crafted by Techno source IT Solutions